Human telomerase RNA (hTR) and human telomerase reverse transcriptase (hTERT) are considered effective molecular targets for current anticancer therapy. In this study, we investigated the therapeutic effects of targeting hTR and hTERT individually or in combination by recombinant adenovirus-delivered small interfering RNA (siRNA) in oral squamous cell carcinoma (OSCC) Tca8113. Further, we screened the optimal strategy for RNA interference. Our results show that these different recombinant adenoviruses specifically reduced the levels of hTR mRNA, hTERT mRNA, hTERT protein and telomerase activity in Tca8113 cells. Moreover, they successfully inhibited xenograft tumor growth in nude mice. The potency of their antitumor activities was ranked as follows: anti-hTR 4anti-hTR þ anti-hTERT 4anti-hTERT. Therefore, we demonstrated that the siRNA-expressing recombinant adenoviruses were an effective anticancer tool for treatment of OSCC. Furthermore, the anticancer effect of solely targeting hTR was more direct and efficient, compared with the effect of targeting hTR and hTERT in combination, or hTERT exclusively. The mechanism of this anticancer effect in OSCC was not only related to the inhibition of cell proliferation and the induction of cell apoptosis, but might also involve the inhibition of tumor angiogenesis.
Introduction
Telomerase is a specific ribonucleoprotein complex that is commonly expressed at a high level in a variety of tumors. It has an important role in tumor initiation and development. Oral squamous cell carcinoma (OSCC), representing B40% of head and neck cancers, is the most prevalent oral malignancy and causes a serious threat to the quality and length of life of patients. As this type of tumor is superficially localized and it is relatively easy to observe the effects of antitumor studies, the prevention and treatment of this disease has always been the focus in the oral cancer research field. Telomerase is upregulated in more than 80% of OSCC, but not in oral normal tissues. 1 Therefore, telomerase represents an attractive anticancer therapeutic target for OSCC. The two essential components of human telomerase are human telomerase RNA (hTR) and human telomerase reverse transcriptase (hTERT). The hTR provides the template sequence, 5 0 -CUAACCCUAAC-3 0 , for telomere synthesis, which is complementary to the telomere sequence (TTAGGG)n. The hTERT catalyzes telomere elongation by reverse transcription and stabilizes the chromosome ends. 2 Recently, increasing attention has been focused on inhibiting telomerase activity by targeting hTR or hTERT to achieve the anticancer effects. 3 RNA interference (RNAi) is the most common and convenient research tool for silencing the expression of oncogenes. 4 The effector molecule, small interfering RNA (siRNA), can be delivered to a specific location by viral vectors in a high-efficiency manner. Owing to its multiple properties, such as safety and transient expression with high efficiency, recombinant adenovirus has been considered an important tool for siRNA delivery. 5, 6 The siRNA delivered by the adenovirus is synthesized by the transcriptional machinery of the host cells, exported to the cytoplasm by exportin-5, (see ref. 7 ) and triggers specific clearance of the target mRNA. Our previous study showed that the hTR-targeting RNAi recombinant adenovirus (Ad-hTR-si) possessed both in vitro and in vivo antitumor activity when it was used to infect Hela cells. 8 In addition, another group reported that simultaneously silencing multiple oncogenes in tumor cells could result in a stronger inhibition of tumor cell proliferation and induction of cell apoptosis. 9 Furthermore, a recent study revealed that hTR and hTERT function in an interdependent manner. 10 Therefore, it is important to understand the overall effects of targeting hTR and hTERT, individually or in combination. Key questions include whether the different interference strategy will knockdown hTR or hTERT gene expression and function to the same extent, and whether, how, and to what extent it may be involved in the regulation of tumor cell proliferation, apoptosis, angiogenesis and other biological behaviors.
Materials and methods
Cells and animals HEK293 (human embryonic kidney cell line, used as adenovirus packaging cells) and Tca8113 (OSCC cell line) cells were purchased from ATCC (Manassas, VA) and cultured in the complete Dulbecco's modified Eagle's medium. Human oral epithelial cells (normal cells, used as control) were grown in primary culture with the keratinocyte cell medium. Four-week-old female BALB/ c nu/nu mice were purchased from the laboratory animal center of Sichuan University and maintained in its animal facilities. All experimental procedures involving animals were done in compliance with institutional and governmental requirements, and approved by the laboratory animal center's Animal Care and Use Committee.
Construction and screening of the RNAi adenoviruses
The siRNA analysis system was used to design the candidate sequences targeting the hTERT gene (GenBank number AF015950). BLAST and AOsearch were used to evaluate the target specificity and off-target effects of these sequences. 11 Three desirable sequences, all with the length of 19 nucleotide, were selected as the specific siRNA targets. These three sequences are localized at different regions of hTERT mRNA: (1) 0 -GACAGTGGTGAA CTTCCCT-3 0 (nucleotides 2761-2779). The hTERTsiRNA-expressing recombinant adenoviruses, Ad-hTERTsi1, Ad-hTERT-si2 and Ad-hTERT-si3, were prepared according to the manufacturer's recommendations using the BD Knockout Adenoviral RNAi System 1 kit (BD, Palo Alto, CA).
8 Tca8113 cells and human oral epithelial cells were infected with these three types of adenoviruses at a multiplicity of infection (MOI) of 50, 100 or 200 in six-well plates. A volume of 2 ml of fresh medium was added to the cells 1-2 h after viral infection for continued culture. These cells were collected after 2 days for measurement of telomerase activity (the method was described in detail below). These cells were also used for screening of the most effective virus and determination of the optimal viral concentration for targeting the hTERT gene. As a result, Ad-hTERT-si1 virus at a MOI of 100 was selected as the optimal condition for the subsequent experiments. The recombinant adenovirus Ad-hTR-si, which targets the template sequence 5 0 -TTGTCTAA CCCTAACTGAG-3 0 in hTR gene (GenBank number U86046) and the negative control recombinant adenovirus Ad-control, which included the negative control siRNA oligonucleotides, had been successfully prepared previously. 8 
Telomerase activity assay
The experiment was performed in four groups: Adcontrol, Ad-hTERT-si, Ad-hTR-si and Ad-hTERT þ Ad-hTR-si (1:1). Tca8113 cells were infected for 48 h with the recombinant adenoviruses, then all cells were collected. A total of 2 Â 10 5 cells were used for the measurement. The telomerase activity assay was performed according to the manufacturer's protocol included in the TeloTAGGG Telomerase PCR ELISAplus kit (Roche, Rotkreuz, Switzerland). As the readout, the A450 value of each experimental sample was measured (with a reference wavelength of 690 nm) and relative telomerase activity was determined by the standard equation. 13 The rate of inhibition of telomerase activity was calculated according to the equation, (A control ÀA hTR/hTERT )/ A control Â 100%.
Real-time quantitative PCR
The Tca8113 cells were collected for total RNA extraction at three different time points: 1 day, 2 days and 3 days after viral infection. Regular reverse transcriptase reaction was performed with the extracted RNA.
14 Quantitative PCR was performed using QUANT SYBR Green PCR reagents (Takara, Dalian, China) based on the manufacturer's protocol. The primers used for hTERT amplification (108 bp) were 5 0 -GCTCCAGGCACAAC GAACG-3 0 and 5 0 -CGCACGCTCATCTTCCACG-3 0 . The primers used for hTR amplification (179 bp) were 5 0 -CTGGGAGGGGTGGTGGCCATTT-3 0 and 5 0 -CGA ACGGGCCAGCAGCTGACAT-3 0 . The primers for the amplification of the internal control, glyceraldehyde-3-phosphate dehydrogenase, were listed in previous publication. 8 The program for PCR amplification was as follows: heat-activation of the enzyme at 95 1C for 10 s, 40 cycles of 95 1C for 5 s and 61 1C for 31 s (data collection), followed by a 10-min final extension at 72 1C. The relative amount of hTERT and hTR mRNA compared with the mRNA level of glyceraldehyde-3-phosphate dehydrogenase was calculated using the 2 ÀDDCt method. 15 The rate of reduction of hTR or hTERT mRNA was normalized to the control group.
Western blotting
The Tca8113 cells were collected for total cellular protein extraction 3 days after viral infection. An equal amount of protein from different samples was separated by 10% SDS-polyacrylamide gel electrophoresis 16 and transferred to a polyvinylidene fluoride transfer membrane. The rabbit monoclonal hTERT (C-term) antibody (122 kDa, hTERT-and hTR-targeting, RNAi adenovirus antitumor Y Li et al Epitomics, Burlingame, CA) was used for western blotting and signals were detected with a chemiluminescent detection kit (Pierce Biotechnology, Rockford, IL). Glyceraldehyde-3-phosphate dehydrogenase was used as the internal control.
Cell proliferation assay A single cell suspension of Tca8113 was seeded into 96-well plate with 100-ml suspension per well (2 Â 10 3 cells/ well) in triplicate. After culture for 18 h, the cells were infected with the recombinant adenoviruses (100 MOI). Cell Counting Kit-8 (Dojindo, Tokyo, Japan) was added into different wells (10 ml per well) from 1 to 7 days after viral infection. The growth curve was generated by the measurement of the A450 value.
Cell apoptosis detection A single cell suspension was prepared with the Tca8113 cells collected at 3 days and 6 days after viral infection. The cells were fixed with 70% pre-cooled ethanol and stained by propidium iodide. The cell concentration was adjusted to 5 Â 10 5 ml À1 and analyzed by flow cytometry. The population of necrotic cells was excluded from the analysis by specific software and the percentage of cells in the subG1 peak represented the percentage of apoptotic cells among the entire population.
In vivo antitumor assay
The subcutaneous xenograft model of OSCC in nude mice was constructed as follows: Tca8113 cells were resuspended in serum-free Dulbecco's modified Eagle's medium and a 0.2 ml cell suspension (5 Â 10 6 ml À1 ) was injected subcutaneously to the right axilla of nude mice. In total, 25 mice were injected. The tumor diameters were measured using a sliding gage every other day and the tumor volumes were calculated according to the equation of V ¼ L Â l 2 Â 0.52 (V, tumor volume; L, long diameter; l, short diameter). After 10 days of tumor growth, when the diameters of most of the xenograft tumors reached 3-6 mm, 20 nude mice with similar tumor volumes were selected and randomly assigned to four groups (five mice per group), namely, the Ad-control, the Ad-hTERT-si, the Ad-hTR-si and the Ad-hTERT-si þ Ad-hTR-si treatment groups. The supernatant containing the corresponding recombinant adenoviruses was injected into the tumor at multiple sites. The injection volume was 0.1 ml per mouse with a virus concentration of 10 10 pfu ml
À1
. After the first injection, the tumor volume was measured every 3 days and a new injection was performed with the same frequency. After 11 injections (a 1 month period), the nude mice were anesthetized and killed gently. The tumors were excised and weighed. Half of the tumor tissue was separated, fixed with 4% paraformaldehyde, embedded in paraffin and sliced for the detection of tumor cell apoptosis by the terminal deoxynucleotidyl transferase-mediated-dUTP nick-endlabeling (TUNEL) assay (Roche, Indianapolis, IN). 8 In each case, five individual Â 400 visual field were analyzed for calculating the apoptosis index, apoptosis index ¼ (TUNEL staining positive cells/tumor cells) Â 100%. The protein expression of vascular endothelial growth factor (VEGF), which served as a marker of angiogenesis, was measured by immunohistochemistry using a VEGF antibody (Santa Cruz, Santa Cruz, CA). 17 Statistics and data analysis All the experiments were performed in triplicate except the animal experiment (n ¼ 5). All of the data are expressed as mean ± s.d. Both analysis of variance and the Poisson distribution test were used for related data analyses by SPSS13.0 (SPSS China, Shanghai, China). Po0.05 was considered statistically significant.
Results

The decrease in telomerase activity in tumor cells
The recombinant adenovirus screening results indicated that Ad-hTERT-si1 had the most potent inhibitory effect on telomerase activity, followed by Ad-hTERT-si3 and Ad-hTERT-si2 (data not shown). The measurements of telomerase activity as a result of single-targeting or cotargeting hTR and hTERT were presented in Table 1 . All the recombinant adenoviruses with different MOI significantly reduced the telomerase activity (Po0.05). The larger the MOI value, the lower the relative telomerase activity value. The Ad-hTR-si group showed the lowest relative telomerase activity value. However, adenoviral infection with an MOI of 200 caused more than 50% tumor cell death, indicating an overdose of the infection reagent. Therefore, we chose an MOI of 100 as the viral infection dose for the subsequent experiments. The Table 1 Relative telomerase activities and the rate of inhibition.
RNAi virus
Ad-control Ad-hTERT-si Ad-hTR-si Ad-hTERT-si+Ad-hTR-si Inhibition of the expression of hTR and hTERT mRNA and the protein expression of hTERT As shown in Figure 1a , infection with Ad-hTR-si and AdhTR-si þ Ad-hTERT-si significantly reduced the levels of hTR mRNA. Especially at day 3 after infection, the reduction reached 74.5 and 52.3%, respectively. However, Ad-hTERT-si failed to inhibit the expression of hTR. In contrast, Ad-hTERT-si and Ad-hTR-si þ Ad-hTERT-si both significantly inhibited the mRNA expression of hTERT and exhibited the most potent effect at day 2. Likewise, Ad-hTR-si did not inhibit the expression of hTERT (Figure 1b) . The western blot results (Figure 1c ) demonstrated that Ad-hTERT-si infection and the combined infection significantly had reduced the hTERT protein expression.
Inhibition of cell proliferation and xenograft tumor growth As shown in Figure 2a , the cell growth curves of all experiment groups were significantly different from the growth curve of the Ad-control group. The Ad-hTR-si group had the lowest growth rate. In the in vivo experiments, the tumor volumes in nude mice were measured and the results were described in Figure 2b . The Ad-hTR-si, Ad-hTERT-si and combination interference groups resulted in significant inhibition of xenograft tumor growth. In addition, the tumor masses isolated from the mice were irregularly shape with some parts in grey and some parts showing necrosis (pictures not shown). The tumor weights of the experiment groups, Ad-hTERT-si (1.56 ± 0.56 g), Ad-hTR-si (0.62 ± 0.40 g) and Ad-hTERTsi þ Ad-hTR-si (1.20±0.52 g), were different compared with the weight in the control group (2.53±0.24 g) and the difference was statistically significant.
Induction of cell apoptosis
Three days after adenovirus infection, Tca8113 cells did not show significant cell apoptosis (the apoptosis rate was around 0.8%). However, at day 6, the apoptosis rates of the experimental groups were 5.01±0.12% (Ad-hTERT-si), 8.54±0.40% (Ad-hTR-si) and 7.20±0.52% (Ad-hTERTsi þ Ad-hTR-si), which were significantly higher than 1.51 ± 0.20% (Ad-control). The tumor sections were analyzed by TUNEL staining. The Ad-control group presented typical squamous cell carcinoma morphology; the cells were arranged in a funicular or nested pattern with few TUNEL-positive cells (shown in red, Figure 3a) . More TUNEL-positive cells were detected in the sections for Ad-hTERT-si, Ad-hTR-si or Ad-hTERT-si þ AdhTR-si groups (Figures 3b-d ). The nuclear chromatin was condensed, pyknotic, or peripherally localized along the nuclear membrane. The chromatin also formed a crescent-like condensation and was segregated into apoptotic bodies. The apoptosis index values of the above three groups were 9.6 ± 1.1, 15.4 ± 1.8 and 12.8 ± 2.3%, respectively. These values showed significant differences 
Reduction of VEGF expression
The VEGF expression in xenograft tumor sections was shown in Figure 4 . The tumor cells in the Ad-control group (Figure 4a ) were arranged in cord or nest forms and the VEGF-positive (shown in brown) staining was located in the cytoplasm of tumor cells or mesenchymal cells. In the Ad-hTERT-si group (Figure 4b ) and AdhTR-si group (Figure 4c) , the number of VEGF-positive cells was significantly decreased and the cellular organization was slightly disordered, showing necrotic properties. In the Ad-hTERT-si þ Ad-hTR-si group (Figure 4d) , the VEGF expression was negative and there was significant cell necrosis.
Discussion
We utilized an in vitro ligation strategy to construct the RNAi adenoviruses Ad-hTR-si and Ad-hTERT-si. We found that the application of these adenoviruses, both individually and in combination, reduced telomerase activity, inhibited cell growth and induced rapid apoptosis in Tca8113 cells. Moreover, the Ad-hTR-si and combination interference groups specifically decreased the mRNA expression of hTR, whereas the Ad-hTERT-si and combination interference groups specifically reduced both the mRNA and protein expression of hTERT. Different recombinant adenoviruses inhibited the xenograft tumor growth, induced apoptosis and necrosis of tumor cells, and reduced angiogenesis.
However, the recombinant adenoviruses from different groups exhibited differential antitumor activities. Specifically, Ad-hTR-si showed the most potent effect, AdhTR-si þ Ad-hTERT-si displayed a moderate effect, and Ad-hTERT-si had the weakest effect. Therefore, targeting hTR would be more effective, sensitive and direct than targeting hTERT. In fact, Shobhanna Natarajan et al. 7, 14 had reported similar findings. Several possible reasons may account for this phenomenon: (1) Compared with the hTERT, the template area of hTR is easier for siRNA molecules to bind to and to promote its splicing function. As the function of the hTR template area is to act as a template for the continuous synthesis of the 5 0 -TTAGGG-3 0 sequence at the end of telomere, its spatial conformation is convenient for complementary binding to the sequence at the end of telomere. Therefore, its spatial conformation also increases the likeliness of binding the siRNA sequence and being subsequently spliced. On the contrary, hTERT mRNA may be more difficult to target because its G/C content is as high as 66%, especially in the region of the first 1000 bp, where the G/C content is as high as 75%. This makes it difficult to find a siRNA target sequence. Although we designed and screened three different siRNAs targeting this gene, the interference effect was still limited. (2) There are multiple exons in the hTERT gene, 18 which means that it may generate different mRNA splice variants through selective splicing in addition to the mature mRNA, which encodes the full-length protein. Therefore, the inhibition of hTR by RNAi may be more complicated than the inhibition of hTERT.
Meanwhile, we found that double gene interference did not produce an additive effect equal to summation of that of the two single-gene interferences. Instead, the effect of combination interference was weaker than solely interfering with hTR, but stronger than solely interfering with hTERT. This indicated that the combined application of two recombinant adenoviruses targeting different genes might be not better than single targeting. This result differs from that reported by other groups. 19 It is possible that the weaker effector, Ad-hTERT-si, neutralizes the effect of the stronger one, Ad-hTR-si. It may also be that there are more important distinct genes or other functions of the known genes in the telomerase complex. For example, scientists have recently discovered a new protein hTERT-and hTR-targeting, RNAi adenovirus antitumor Y Li et al in maintaining the stability of hTR and construction of ribonucleoproteins. Therefore, elucidation of the composition and function of the telomerase complex will provide the basis for the combination interference strategy of silencing multiple genes. The recombinant adenoviruses targeting hTERT or hTR inhibited the proliferation of siRNA-treated Tca8113 cells. The inhibitory effect was modest, but in keeping with the modest reduction of tumor volume in nude mice at the initial RNAi adenoviruses infection. But at day 30, the inhibition tendency lines of tumor volume appeared significantly dropping out. It suggested that the capacity of the adenovirus-delivered siRNAs to inhibit cell and tumor growth was in accord with other telomerase inhibitors, which often lead to a delayed progressive inhibition of cell growth only after sufficient telomere shortening upon many cycles of cell division. The RNAi adenoviruses could suppress the growth of xenograft tumors in nude mice, but fail to stop the cell growth or cause the tumor to disappear completely. There are several possible explanations: (1) the gene carried by the recombinant adenovirus remains episomal and can only transiently express siRNA in a highly efficiency manner; thus, its effect on gene silencing and tumor inhibition is obvious, but relatively transient. However, the adenovirus is able to achieve a higher viral titer compared with lentivirus or retrovirus, and the higher copy number of the virus can lead to the significantly higher expression of siRNA. 20 This feature makes adenovirus a more effective gene silencing tool; (2) the injection of recombinant adenovirus into multiple sites of the xenograft tumor in nude mice cannot guarantee that the viral particles will be evenly distributed in all the tumor cells, such that the anti-tumor effect is limited. Meanwhile, the recombinant adenovirus also induced rapid cell apoptosis (6 days), and this did not depend on the regular mechanism of telomere shortening to a certain threshold that triggers apoptosis. This time period is called the lag phase. Our recombinant adenovirus might shorten the lag phase so that tumor cells death was induced more effectively and rapidly. In fact, antisense oligonucleotides and hammerhead ribozymes have the same effect. 21, 22 This effect may also be due to the induction of a mitochondria-mediated endogenous apoptosis pathway or direct apoptosis induction in tumor cells after the inhibition of hTERT. 22 VEGF is highly expressed in many human cancers. 23 Its expression is positively related to angiogenesis. The tumor sections of nude mice displayed significant carcinoma necrosis in the tumor masses (visible by both naked-eye observation and immunochemistry detection), which corresponded to the decreased expression of VEGF. The reduced levels of VEGF may be associated with the inhibition of hTERT 24 or hTR expression. 25 A study by Cong YS et al. 24 showed that inhibiting the endogenous hTERT level in Hela cells with siRNA reduced the transcription and expression of VEGF. Other studies have shown that VEGF and hTERT or telomerase are highly associated in certain types of cancers and can regulate each other. 26, 27 Our study showed that inhibition of hTR and hTERT by RNAi, both individually and in combination, had effective antitumor activity. The mechanism of this activity may be related to the inhibition of tumor cell proliferation, the induction of cell apoptosis and the reduction of tumor angiogenesis. However, the effect of silencing hTR was more direct and efficient than that of silencing hTERT. Therefore, the RNAi adenovirus targeting hTR may potentially be useful as an effective tool for gene therapy for OSCC.
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